Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	19.77	23.28	19.44
Graham Fair Price	-16.97	36245.20	43655.36
PEG	-70.80	-0.43	1.46
Price/Book	-4.56	1.15	1.21
Price/Cash Flow	-49.69	8.20	16.30
Prices/Earnings	35.42	12.89	9.52
Price/Sales	-0.33	0.57	0.58
Price/FCF	-49.69	8.20	16.30
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-9.02	0.14	0.15
Operating Margin	-33.66	0.02	0.03
ROA	-26.22	< 0.005	0.01
ROE	0.03	0.02	-29.52
ROIC	0.03	0.02	-30.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	-0.08	40.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.31	-0.37	20.37
EPS QOQ	0.07	-0.30	363.75
FCF QOQ	17.07	0.88	-94.87
Revenue QOQ	0.02	-0.05	215.61
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	27.06	23.20	-14.29
Days Sales Outstanding (DSO)	34.23	31.32	-8.50
Inventory Turnover	3.33	3.88	16.67
Debt/Capitalization	0.54	0.41	-23.56
Quick Ratio	0.52	0.52	-0.42
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	51696.63	51126.37	-1.10
Cash	2500.15	3744.84	49.78
Capex	-1486.75	-1567.67	-5.44
Free Cash Flow	3827.81	7182.23	87.63
Revenue	108214.92	102481.54	-5.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.86	0.83	-2.84
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.53	11.34	18.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating